Harvard Bioscience Inc (HBIO)
3.82
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
3.82
0.00 (0.00%)
After-Hours: 19:11
Harvard Bioscience Cash from Financing (Quarterly): -4.116M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.116M |
| September 30, 2023 | -2.75M |
| June 30, 2023 | -2.375M |
| March 31, 2023 | -2.893M |
| December 31, 2022 | -2.73M |
| September 30, 2022 | 0.377M |
| June 30, 2022 | -0.578M |
| March 31, 2022 | 0.094M |
| December 31, 2021 | 2.594M |
| September 30, 2021 | 0.487M |
| June 30, 2021 | -0.192M |
| March 31, 2021 | -3.141M |
| December 31, 2020 | 3.357M |
| September 30, 2020 | -0.953M |
| June 30, 2020 | -5.30M |
| March 31, 2020 | -5.071M |
| December 31, 2019 | -0.429M |
| September 30, 2019 | -0.658M |
| June 30, 2019 | -1.533M |
| March 31, 2019 | -5.004M |
| December 31, 2018 | -0.354M |
| September 30, 2018 | 2.702M |
| June 30, 2018 | -0.539M |
| March 31, 2018 | 51.24M |
| December 31, 2017 | -0.439M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.724M |
| June 30, 2017 | -0.361M |
| March 31, 2017 | -0.268M |
| December 31, 2016 | -1.21M |
| September 30, 2016 | -1.024M |
| June 30, 2016 | -0.908M |
| March 31, 2016 | -1.726M |
| December 31, 2015 | -1.161M |
| September 30, 2015 | -0.411M |
| June 30, 2015 | 0.20M |
| March 31, 2015 | 0.832M |
| December 31, 2014 | -1.099M |
| September 30, 2014 | 1.364M |
| June 30, 2014 | -0.568M |
| March 31, 2014 | -0.931M |
| December 31, 2013 | -12.48M |
| September 30, 2013 | -0.751M |
| June 30, 2013 | 9.696M |
| March 31, 2013 | 3.602M |
| December 31, 2012 | -0.524M |
| September 30, 2012 | -0.74M |
| June 30, 2012 | -0.566M |
| March 31, 2012 | 0.767M |
| December 31, 2011 | 0.113M |
| September 30, 2011 | -0.681M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-5.30M
Minimum
Jun 2020
3.357M
Maximum
Dec 2020
-1.358M
Average
-0.953M
Median
Sep 2020
Cash from Financing (Quarterly) Benchmarks
| Bruker Corp | -59.90M |
| Azenta Inc | -113.15M |
| Bionano Genomics Inc | 68.48M |
| Akoya Biosciences Inc | 11.08M |
| Singular Genomics Systems Inc | 0.072M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 4.303M |
| Cash from Investing (Quarterly) | -1.061M |
| Free Cash Flow | 11.72M |
| Free Cash Flow Per Share (Quarterly) | 0.076 |
| Free Cash Flow to Equity (Quarterly) | 5.422M |
| Free Cash Flow to Firm (Quarterly) | 4.551M |
| Free Cash Flow Yield | 7.20% |